Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06466317

Is There Effect of Adding Honey Intake to Free Walking in Metabolic Syndrome Children

Response of Metabolic Syndrome Components to Adding Honey Consumption to Free Walking Exercise in Children

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Ahram Canadian University · Academic / Other
Sex
All
Age
9 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Metabolic Syndrome is common in Children and complementary therapies are important in its treatment such exercise and functional food intake including honey.

Detailed description

Forty Children with metabolic syndrome will Assigned to group of free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking was supervised by authors via Videoconferencing Imo Program) and this group also will receive healthy dietary guidelines in addition to consuming natural honey for 12 weeks.. The other group that will contain 20 patients will take only free walking exercise and healthy diet guidelines for 12 weeks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHoney intake with walking exercise20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines in addition to consuming natural honey (2ml/kg honey will be taken.. This dose will be divided into two halves, the first half will be taken at 7 am and the other half will be taken at 7 pm for 12 weeks)
BEHAVIORALWalking exercise20 Children with metabolic syndrome will receive free walking continuous exercise (thirty minutes daily in nearby sport club in the presence of their parents and walking will supervised by authors via Videoconferencing Imo Program) and this group also will healthy diet guidelines for 12 weeks)

Timeline

Start date
2024-06-06
Primary completion
2024-10-01
Completion
2024-10-01
First posted
2024-06-20
Last updated
2024-06-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06466317. Inclusion in this directory is not an endorsement.